BIO Asia–Taiwan 2023 亞洲生技大會

BIO Asia–Taiwan 2023 亞洲生技大會


Jim Long

Session 9 – Winning the Global Competition with Taiwanese DNA

Date:28 July (Thursday)
Time:  14:00 – 15:30 (GMT+8)

Jim Long

AESOP Technology Inc.

AESOP Technology is a spin-off from TMU, founded by experts of medical informatics, physicians, pharmacist, AI engineers, data scientist. Mission: to increase patient safety and quality by bring next-generation medical AI to prescription.

AESOP uses Machine Learning on 3.2 billion patient visits to make physician data entry easier, faster and less error prone.

AESOP’s vision is to improve quality, safety and efficiency of healthcare systems through a new paradigm in clinical decision support we call “Deep Clinical Decision Support”. This paradigm involves providing physicians with intelligent workflow support that enables them to seamlessly understand best practice for the full range of diseases, medications and procedures in every clinical context.

This can only be enabled through data mining on large sets of structured and unstructured clinical data, and with deep integration into a the clinical systems needed to provide the appropriate workflow support.

Jim Long is CEO and co-founder of AESOP, with more than 20 years of experience in leveraging technology to drive organizational growth, operational efficiency, and optimizing utilization of emerging technologies. He has been the CIO at Wanfang medical center and research associate in the Institute of Nuclear Energy Research. He has diverse experience in startup and mature environments with extensive software knowledge in various industries and also served as the R&D manager of ATMA Champ Ent Corp and the CTO of Landrex Technologies.


Speech title & Synopsis

Panel Discussion: How Do We Survive and Thrive?